1 |
Ansbacher, R., Selective estrogen receptor modulators. Am. J. Obstet. Gynecol., 181, 1036 (1999)
PUBMED
|
2 |
Brzezinski, A. and Debi, A., Phytoestrogens: the 'natural' selective estrogen receptor modulators? Eur. J. Obstet. Gynecol. Reprod. Biol., 85, 47-51 (1999)
DOI
ScienceOn
|
3 |
Cassidy, A., Bingham, S., and Setchell K. D., Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am. J. Clin. Nutr., 60, 333-340 (1994)
DOI
PUBMED
|
4 |
Choi, Y. H., Zhang, L., Lee, W. H., and Park, K. Y., Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Int. J. Oncol., 3, 391-396 (1998)
|
5 |
Fotsis, T., Pepper, M. S., Aktas, E., Breit, S., Rasku, S., Adlercreutz, H., Wahala, K., Montesano, R., and Schweigerer, L., Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res., 57, 2916-2921 (1997)
PUBMED
|
6 |
Jorgensen, M., Vendelbo, B., Skakkebaek, N. E., and Leffers, H., Assaying estrogenicity by quantitating the expression of endogenous estrogen-regulated genes. Environ. Health Perspect, 108, 403-412 (2000)
DOI
ScienceOn
|
7 |
Kuzumaki, T., Kobayashi, T., and Ishikawa, K., Genistein induces p21(Cip1/WAF1) expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells. Biochem. Biophys. Res. Commun., 251, 291-295 (1998)
DOI
ScienceOn
|
8 |
Nishikawa, J., Saito, K., Goto, J., Dakeyama, F., Matsuo, M., and Nishihara, T., New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. Toxico. Appl. Pharmacol., 154, 76-83 (1999)
DOI
ScienceOn
|
9 |
Sumpter, J. P. and Jobling, S., Vitellogenesis as a biomarker for estrogenic contamination of the aquatic environment. Environ. Health Perspect, 103,173-178 (1995)
DOI
PUBMED
|
10 |
Wang, T. T., Sathyamoorthy, N., and Phang, J. M., Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis, 17, 271-275 (1996)
DOI
ScienceOn
|
11 |
Fioravanti, L., Cappelletti, V., Miodini, P., Ronchi, E., Brivio, M., and Di Fronzo, G., Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro. Cancer Lett., 130, 143-152 (1998)
DOI
PUBMED
ScienceOn
|
12 |
Gaido, K. W., Leonard, L. S., Lovell, S., Gould, J. C., Babai, D., Portier, C. J., and MacDonell, D. P., Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor transcription assay. Toxicol. Appl. Pharmacol., 143, 205-212 (1997)
DOI
ScienceOn
|
13 |
Morito,, K., Aomori T., Hirose, T., Kinjo J., Hasegawa, J., Ogawa, S., Inoue, S., Muramatsu, M., and Masamune, Y., Interaction of Phytoestrogens with Estrogen Receptors and (II). Biol. Pharm. Bull., 25, 48-52 (2002)
DOI
ScienceOn
|
14 |
Soto, A. M., Sonnenschein, C., Chung, K. L., Fernandes, M. F., Olea, N., and Serrano, F. O. The E-SCREEN assay as a tool to identify estrogens : an update on estrogenic environmental pollutants. Environ. Health Perspect, 103,113-122 (1995)
DOI
PUBMED
|
15 |
Breinholt, V. and Larsen, J. C., Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay. Chem. Res. Toxicol., 11, 622-629 (1998)
DOI
ScienceOn
|
16 |
Constantinou, A. I., Kamath, N., and Murley, J. S., Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur. J. Cancer, 34, 1927-1934 (1998)
DOI
ScienceOn
|
17 |
Andersen, H. R., Andersson, A. M., Arnold, S. F., Autrup, H., Barfoed, M., Beresford, N.A., Bjerregaard, P., Christiansen, L. B., Gissel, B, Hummel, R., Jorgensen, E. B., Korsgaard, B., Le Guevel, R., Leffers, H., McLachlan, J., Moller, A., Nielsen, J. B., Olea, N., Oles-Karasko, A., Pakdel, F., Pedersen, K. L., Perez, P., Skakkeboek, N. E., Sonnenschein, C., and Soto, A. M. et al., Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ. Health Perspect, 107, 89-108 (1999)
DOI
PUBMED
|
18 |
Klein, K. O., Baron, J., Colli, M. J., McDonnell, D. P., and Cutler, G. B. Jr., Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J. Clin. Invest., 94, 2475-2480 (1994)
DOI
ScienceOn
|
19 |
Noroozi, M., Angerson, W. J., and Lean, M. E., Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am. J. Clin. Nutr., 67, 1210-1218 (1998)
DOI
PUBMED
|
20 |
Bolger, R., Wiese, T. E., Ervin, K., Nestich, S., and Checovich, W., Rapid screening of environmental chemicals for estrogen receptor binding capacity. Environ. Health Prespect, 106, 551-557(1998)
DOI
ScienceOn
|
21 |
Xu, X., Duncan, A. M., Merz, B. E., and Kurzer, M. S., Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol. Biomarkers Prev., 7, 1101-1108 (1998)
PUBMED
|
22 |
Masamura, S., Santner, S. J., Heitjan, D. F., and Santen, R. J., Estrogen deprivation causes estradiol hypersensitivitiy in human breast cancer cells. J. Clin. Endocrinol. Metab., 80, 2918-2925 (1995)
DOI
ScienceOn
|
23 |
Weryha, G., Pascal-Vigneron, V., Klein, M., and Leclere, J., Selective estrogen receptor modulators. Curr. Opin. Rheumatol., 11, 301-306 (1999)
DOI
ScienceOn
|
24 |
Meyer, T., Koop, R., Von Angerer, E., Schonenberger, H., and Holler, E., A rapid luciferase transfection assay for transcription activation effects and stability control of estrogenic drugs in cell cultures. J. Cancer Res. Clin. Oncol., 120, 359-364 (1994)
DOI
ScienceOn
|
25 |
Andersson, A. M. and Skakkebaek, N. E., Exposure to exogenous estrogens in food: possible impact on human development and health. Eur. J. Endocrinol., 140, 477-485 (1999)
DOI
PUBMED
|
26 |
Hochner-Celnikier, D., Pharmacokinetics of raloxifene and its clinical applications. Eur. J. Obstet. Gynecol. Reprod. Biol., 85, 47-51 (1999)
DOI
ScienceOn
|
27 |
Delmas, P. D., Clinical use of selective estrogen receptor modulators. Bone, 25, 115-118 (1999)
DOI
PUBMED
ScienceOn
|